Curaleaf Completes Acquisition of Grassroots’ License in Arizona

— Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced that Curaleaf has completed  the acquisition from Grassroots of exclusive rights to the Grassroots’ All Rebels Rockers, Inc. marijuana license in Arizona. The transaction was completed in advance of the closing of Curaleaf’s acquisition ofContinue reading “Curaleaf Completes Acquisition of Grassroots’ License in Arizona”

MediPharm Labs to Participate at CBD BioPharma Virtual Investor Conference

 — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that MediPharm Labs’ management will participate in the CBD BioPharma Virtual Investor Conference on Thursday, July 9th.  The audio webcast presentation will begin atContinue reading “MediPharm Labs to Participate at CBD BioPharma Virtual Investor Conference”

Namaste Technologies Reports Second Quarter 2019 Financial Results

– July 18, 2019 Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced its interim financial results for the second quarter ended May 31, 2019. All financial figures are in Canadian dollars unless otherwise indicated. SECOND QUARTER 2019 HIGHLIGHTS Consolidated revenue remains consistent at $4.0 million compared with $4.1Continue reading “Namaste Technologies Reports Second Quarter 2019 Financial Results”

Auxly’s Subsidiary Dosecann Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects

— Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, is thrilled to announce that its wholly owned subsidiary, Dosecann LD Inc. (“Dosecann”) has received its Cannabis Research Licence from Health Canada pursuant to the Cannabis Act. This licence permits Dosecann to administer cannabis extracts, edible cannabisContinue reading “Auxly’s Subsidiary Dosecann Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects”

MediPharm Labs Expands Innovative CBD Product Portfolio By Introducing CBD25:5 Release Formula

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced a further expansion of its innovative, pharma-quality family of branded products with the retail introduction of CBD25:5 Release Formula(“CBD25:5”). This latest brand – the third launched from MediPharm Labs’ GMP-certifiedContinue reading “MediPharm Labs Expands Innovative CBD Product Portfolio By Introducing CBD25:5 Release Formula”

Delta 9 Enters into Cannabis Supply Agreement with Ontario Cannabis Store

— DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that on June 23, 2020 it entered into a Master Cannabis Supply Agreement (the “Agreement”) with Ontario Cannabis Retail Corporation (doing business as “Ontario Cannabis Store”) (“OCS”). The Agreement provides for the supply by Delta 9 ofContinue reading “Delta 9 Enters into Cannabis Supply Agreement with Ontario Cannabis Store”

Ayr Strategies to Hold First Quarter 2020 Conference Call on Thursday, May 21, 2020 at 8:30 a.m. ET

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — Vertically-integrated cannabis multi-state operator (MSO), Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr”), will hold a conference call on Thursday, May 21, 2020 at 8:30 a.m. Eastern time to discuss its results for the first quarter ended March 31, 2020. The Company will provide its financial results inContinue reading “Ayr Strategies to Hold First Quarter 2020 Conference Call on Thursday, May 21, 2020 at 8:30 a.m. ET”

Aleafia Health Announces $13 Million Bought Deal Offering of Units

TORONTO, May 11, 2020 (GLOBE NEWSWIRE) — NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF)  (“Aleafia” or the “Company”), is pleased to announce that it has entered into an agreement with Eight Capital as lead underwriter and sole bookrunner, on behalf ofContinue reading “Aleafia Health Announces $13 Million Bought Deal Offering of Units”

Aurora Cannabis Confirms Share Consolidation Effective Date

Common shares of the Company will begin trading on the New York Stock Exchange and the Toronto Stock Exchange on a post-consolidated basis at the opening of trading on May 11, 2020 EDMONTON, May 8, 2020 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora“) (NYSE |TSX: ACB), the Canadian company defining the future of cannabis worldwide, confirms todayContinue reading “Aurora Cannabis Confirms Share Consolidation Effective Date”